Fortress Biotech Inc - Company Profile
Powered by 
All the data and insights you need on Fortress Biotech Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Fortress Biotech Inc Strategy Report
- Understand Fortress Biotech Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Business Description
Fortress Biotech Inc (Fortress Biotech) is a diversified company that acquires, develops and commercializes novel immunotherapy biologic agents for the treatment of cancer and other autoimmune diseases.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
R&D Overview
Fortress Biotech conducts research to develop and commercialize novel pharmaceutical and biotechnology products for the treatment of T-cell acute lymphocytic leukemia, lung cancer, renal cell carcinoma, acute lymphocytic leukemia, and for post-operative pain. In FY2022, the company spent US$134.8 million on its R&D activities, which grew 4.7% YoY.
Business Segments
Overview
-Develops, acquires, licenses, and commercializes branded dermatology products. -Carries out its operations through its subsidiary, Journey Medical Corp. -Major brands involve Ximino, Targadox, Exelderm, Ceracade Luxamend.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Overview
- Advances the development of in-licensed product candidates. - Focuses on developing multiple treatments for a range of diseases, including immune deficiencies, cancers, genetic disorders, and other rare diseases. It also focuses on working on a long-lasting version of a medication called methazalomide for different uses.
Performance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer